Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1EPRATUZUMAB
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
2Epratuzumab 100 mg
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
3Epratuzumab 1200 mg
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
4Epratuzumab 400 mg
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
5Epratuzumab 600 mg
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
6Epratuzumab iv
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
7Epratuzumab sc
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬
8HLL2 (Epratuzumab)
(D04036)		[1] Epratuzumab[1] Epratuzumab (D04036) 💬[1] CD22 💬[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬[1] 49 💬